PlainRecalls
FDA Drug Moderate Class II Terminated

Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877

Reported: June 9, 2021 Initiated: May 4, 2021 #D-0600-2021

Product Description

Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877

Reason for Recall

Subpotent Drug

Details

Units Affected
15,198 bottles (30 tablets per bottle)
Distribution
AR, CO, CT, LA, NC, ND, NH, NJ, OH, PA and PR
Location
Ridgefield, CT

Frequently Asked Questions

What product was recalled?
Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877. Recalled by Boehringer Ingelheim Pharmaceuticals, Inc.. Units affected: 15,198 bottles (30 tablets per bottle).
Why was this product recalled?
Subpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on June 9, 2021. Severity: Moderate. Recall number: D-0600-2021.